"Pharmaceutical Headlines" follows Gilead and AbbVie as another giant into CD47

(2020/09/14) Ha Pharmaceuticals Group's acquisition of GNC U.S. Senators requires a national security review; The drug company won five first-half imitation 9 products reviewed; islet cell skin transplant breakthrough New technology successfully reversed type 1 diabetes ... (Click on the title to get the original article) After Gilead and AbbVie entered CD47 on Tuesday (September 8), Pfizer made a $25 million equity investment to buy about 2.3 million common shares of Trillium Therapeutics at $10.88 a share, 15 percent higher than its September 4 closing price.
trading, Trillium Therapeutics was courted by investors and its shares soared 43 per cent on September 9.
: its potential market could also reach $20 billion.
invested more than 1.5 billion dollars in research and development! China Biopharmaceuticals reported first-half 2020 results with revenue of 12.648 billion yuan and net profit of 1.213 billion yuan.
, 10 major products accounted for more than 100 million yuan in sales, and new product sales grew rapidly, accounting for nearly 35% of total revenue.
Research and development, China Biopharmaceuticals in the first half of the total research and development expenditure of more than 1.5 billion yuan, access to production approval 12 pieces, won the Entourta bintin nofovir tablets, Dabiga group ester capsules, phosphate siglitin tablets, inhalation with Budinide mixed suspension and other 5 products first imitation, 9 varieties over-evaluation, anti-PD-1 single anti-drug Pa ample 1 class of new drug listing application in the review (in the drug review center).
headlines: Actively explore "Internet plus Medical".
(Medical Rubik's Cube) Islet cell offskin transplant breakthrough New technology successfully reversed type 1 diabetes type 1 diabetes is an autoimmune disease, the pathogenesis is the immune system mistakenly attack islet β cells, resulting in insufficient insulin secretion, the body can not maintain normal blood sugar levels.
for people with type 1 diabetes, long-term insulin injections combined with blood sugar monitoring are essential treatments.
, however, daily injections can not only cause great pain to patients, but can also lead to complications such as hypoglycemia, epilepsy and coma, and can lead to death.
, scientists have been looking for better treatments.
: Islet-IVM mixture transplantation provides important support for the development of new treatment models for type 1 diabetes.
Pfizer Korea Employee Compensation Determined that Mercadon employees are strongly concerned ... According to South Korean media reports last week, Pfizer Korea said it would pay compensation of 12 million won (about 69,000 yuan) per employee for the spin-off, and that it was known that Puqiang and Mylan would merge into a new company, Viatris, and that Pfizer and Mylan had jointly released VIATRIS logos and brand images on July 9 this year.
: Pfizer and Mercedon have similar approvals in South Korea.
(Reuters) - U.S. Sen. Marco Rubio on Sept. 10 called for a national security review of the group's plan to buy GNC (Chinese: Health and Wellness), Reuters reported.
letter to Treasury Secretary Mnuchin, Rubio asked the CfIUS to conduct a full review of the acquisition of GNC.
CFIUS is part of the U.S. Treasury Department and was established in 1988 to protect national security and focus on foreign investment approval systems.
headlines: Does GNC have sensitive data?